| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Robertson H. Gilliland is Director at ADIL. Robertson H. Gilliland's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $46K at current prices.
Net of sales, the ADIL filings show accumulation of 14,000 shares.
Robertson H. Gilliland has 8 Form 4 filings on record from July 2018 to April 2026, all as Director at Adial Pharmaceuticals (ADIL), 2018–2026.
The 10 reported transactions were 6 option or other derivative awards, 2 open-market purchases, 1 stock award and 1 conversion.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2018 | ADIL Adial Pharmaceuticals, Inc. | Director | Buy | 14,000 | $0.00 | - | +14.7% |